Spots Global Cancer Trial Database for bryostatin 1
Every month we try and update this database with for bryostatin 1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome | NCT00003171 | Leukemia Myelodysplastic... | bryostatin 1 | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | NCT00006389 | Stage III Gastr... Stage IV Gastri... | bryostatin 1 cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer | NCT00005028 | Prostate Cancer | bryostatin 1 paclitaxel | 18 Years - | University of Maryland, Baltimore | |
| Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00112476 | Recurrent Melan... Recurrent Renal... Stage IV Melano... Stage IV Renal ... Unspecified Adu... | bryostatin 1 temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT00136461 | Acute Myelogeno... Myelodysplastic... | All-trans retin... Bryostatin 1 | 18 Years - | Dana-Farber Cancer Institute | |
| Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | NCT00002908 | Leukemia Lymphoma | bryostatin 1 vincristine sul... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer | NCT00003108 | Unspecified Adu... | bryostatin 1 cisplatin | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia | NCT00003174 | Leukemia | bryostatin 1 cladribine | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer | NCT00005849 | Lung Cancer | bryostatin 1 paclitaxel | 18 Years - | University of Chicago | |
| Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | NCT00003220 | Colorectal Canc... | bryostatin 1 | - | Barbara Ann Karmanos Cancer Institute | |
| Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors | NCT00003242 | Unspecified Adu... | bryostatin 1 cisplatin paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease | NCT00003936 | Lymphoma | bryostatin 1 | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer | NCT00006022 | Kidney Cancer Melanoma (Skin) | aldesleukin bryostatin 1 | 18 Years - 120 Years | Virginia Commonwealth University | |
| Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease | NCT00003936 | Lymphoma | bryostatin 1 | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00002725 | Lymphoma | bryostatin 1 chemotherapy | - | National Cancer Institute (NCI) | |
| Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer | NCT00031694 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... | paclitaxel bryostatin 1 | 19 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma | NCT00003079 | Leukemia Lymphoma | bryostatin 1 cytarabine | 18 Years - | Virginia Commonwealth University | |
| Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma | NCT00002907 | Multiple Myelom... | bryostatin 1 | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer | NCT00003108 | Unspecified Adu... | bryostatin 1 cisplatin | 18 Years - | National Cancer Institute (NCI) | |
| A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT00136461 | Acute Myelogeno... Myelodysplastic... | All-trans retin... Bryostatin 1 | 18 Years - | Dana-Farber Cancer Institute | |
| Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer | NCT00032188 | Recurrent Renal... Stage III Renal... Stage IV Renal ... | aldesleukin bryostatin 1 laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | NCT00003443 | Head and Neck C... | bryostatin 1 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer | NCT00004008 | Ovarian Cancer | bryostatin 1 | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer | NCT00003968 | Kidney Cancer | bryostatin 1 | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 In Treating Patients With Progressive Kidney Cancer | NCT00005056 | Kidney Cancer | bryostatin 1 | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer | NCT00012376 | Accelerated Pha... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Chronic Myelomo... Chronic Phase C... Paroxysmal Noct... Previously Trea... Recurrent Adult... Refractory Anem... Refractory Anem... Relapsing Chron... Thrombocytopeni... Untreated Adult... | bryostatin 1 sargramostim laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 in Treating Patients With Stage IV Breast Cancer | NCT00003205 | Breast Cancer | bryostatin 1 | 18 Years - | University of Colorado, Denver | |
| Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | NCT00003443 | Head and Neck C... | bryostatin 1 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | NCT00006389 | Stage III Gastr... Stage IV Gastri... | bryostatin 1 cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia | NCT00017342 | Leukemia | bryostatin 1 cytarabine | 18 Years - | Virginia Commonwealth University | |
| Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer | NCT00005849 | Lung Cancer | bryostatin 1 paclitaxel | 18 Years - | University of Chicago | |
| Bryostatin and Vincristine in B-Cell Malignancies | NCT00003166 | Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Mantl... Refractory Chro... Refractory Mult... Stage III Multi... | bryostatin 1 vincristine sul... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer | NCT00005599 | Esophageal Canc... Gastric Cancer | bryostatin 1 paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | NCT00003443 | Head and Neck C... | bryostatin 1 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer | NCT00003132 | Unspecified Adu... | bryostatin 1 cisplatin | 18 Years - | NYU Langone Health | |
| Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | NCT00006942 | Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | bryostatin 1 cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | NCT00004144 | Unspecified Adu... | bryostatin 1 gemcitabine hyd... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix | NCT00005965 | Cervical Cancer | bryostatin 1 cisplatin | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia | NCT00017342 | Leukemia | bryostatin 1 cytarabine | 18 Years - | Virginia Commonwealth University | |
| Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors | NCT00003242 | Unspecified Adu... | bryostatin 1 cisplatin paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | NCT00087425 | Leukemia Lymphoma | rituximab bryostatin 1 | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation | NCT00058305 | Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Splenic Margina... | bryostatin 1 vincristine sul... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer | NCT00004008 | Ovarian Cancer | bryostatin 1 | 18 Years - | National Cancer Institute (NCI) | |
| Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | NCT00004144 | Unspecified Adu... | bryostatin 1 gemcitabine hyd... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer | NCT00006022 | Kidney Cancer Melanoma (Skin) | aldesleukin bryostatin 1 | 18 Years - 120 Years | Virginia Commonwealth University | |
| Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer | NCT00005028 | Prostate Cancer | bryostatin 1 paclitaxel | 18 Years - | University of Maryland, Baltimore | |
| Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | NCT00006389 | Stage III Gastr... Stage IV Gastri... | bryostatin 1 cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer | NCT00006022 | Kidney Cancer Melanoma (Skin) | aldesleukin bryostatin 1 | 18 Years - 120 Years | Virginia Commonwealth University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
